Here is a little piece wrote by Synapsin comparing Cycle Assist to another popular support product..check the references at the end--
Competitive Edge Lab’s (CEL) Cycle Assist
Cycle Assist is designed to be an all-in-one support solution for basic on cycle and post cycle therapy needs. Cycle Assist contains a combination of specifically dosed ingredients designed to help provide liver, blood pressure, cholesterol, prostate, and acne support (1-35).
Also, unlike many other products in its class, every herb in Cycle Assist is a standardized extract and the standardization amount is clearly identified on the label. This is extremely important because it is the amount of active ingredient that an herb is standardized for that determines the level of benefits received from it. Example: A product can be dosed very high in mg of herb powder, but standardized poorly and therefore offer very little if anything in terms of effectiveness.
This article will serve as a comprehensive guide to the most important ingredients in Cycle Assist.
N-Acetyl-l-Cysteine (NAC) is used in the management of drug overdose (such as acetaminophen), and acts as a mucolytic agent. The inclusion of NAC in Cycle Assist is due to its protective effects on the liver and kidney. It is possibly one of the most effective over the counter products available on the market for protecting your liver from damage (1-13).
Milk Thistle is perhaps one of the most famous herbs in the world, widely known for its liver protective effects. Research on milk thistle has suggested that it is both capable of preventing liver damage AND repairing liver damage (14-18).
Pantothenic Acid has been shown to lower free cholesterol, triglyceride counts, and total cholesterol in the liver (19).
Hawthorn Berry Extract has been shown to potentially help with chronic heart failure, fatigue, palpitations, and dyspnea (20-21).
Vitamin B-6 (Pyridoxine HCl) can protect individuals from cardiovascular disease by lowering homocysteine levels in the blood (22-23).
Saw Palmetto Extract is a popular men’s health herbal product, most commonly used for benign prostatic hyperplasia. Users often take it while on cycle for prostate health benefits. It has also been suggested to help with male pattern baldness (24-28).
Celery Seed Extract has been suggested to lower blood sugar, decrease blood pressure, promote relaxation, and protect the liver from damage (29-30).
Grape Seed Extract can potentially improve symptoms of hypertension, lower high levels of blood cholesterol, inflammation, and improve liver function (31-33).
Policosanol can potentially improve your cholesterol levels by lowering levels of LDL (bad cholesterol) while simultaneously improving levels of HDL (good cholesterol) (34-35).
Antaeus Labs Talos
Since the release of CEL’s Cycle Assist, many companies have tried to release their own version of Cycle Assist, but they all pale in comparison to Cycle Assist, the best on cycle product on the market. One such product is Antaeus Labs’ product “Talos”. A comprehensive review of the literature has revealed that this product is nothing more than pixie dust, filled with many ingredients at either meaningless doses, lacking any extract information, or ingredients that have zero applications in humans (with little to no animal research either).
The only overlapping ingredients in Talos that overlaps with Cycle Assist is Vitamin B6. Cycle Assist not only states what form of Vitamin B6 we use (this actually matters), but also has a higher dosage of B6.
The main ingredients in Talos are the following:
Prunus Cerasus (Sour Cherry)
Matrine
Trans-Resveratrol
Dunaliella salina extract (10% 9-Cis-Beta Carotene)
Salicin
Astaxanthin
Prunus Cerasus (Sour Cherry) only has one real study on it. The study has no data on its usage in humans, its only data conducted on cell cultures, and it’s only suggested function is that it may act as an antioxidant. It is virtually useless for usage as an on cycle product (36).
Matrine has been suggested to act as an analgesic and an anti-cancer agent, but again, that is irrelevant to an individual running a cycle. Its anti-cancer properties (specifically breast cancer) would be more relevant for usage during PCT rather than on cycle, and it has no human data to confirm such a conclusion that is indeed effective for that usage (37-38).
Trans-Resveratrol is a very popular buzz product (and it has been the last few year), but nobody is quite sure what it actually does yet. It suffers from huge bio-availability issues (oral resveratrol bio-availability is nearly zero), and the dose in Talos (50 mg), is worthless in humans (39).
Dunaliella salina extract (10% 9-Cis-Beta Carotene) is a head scratcher. It has one study on the effects of cancer of proventriculus in mice, and a few studies evaluating its efficacy as a potential antimicrobial. This ingredient has no place in an on cycle product, and truly shows how much of a filler in is (40-41).
Salicin is the one ingredient in this product has that any real benefit, but the dosage in this product is far too low for users to feel any benefit.
Astaxanthin is similar to Dunaliella salina extract in that it is an antioxidant that neutralizes free radicals in the eye and nervous system. Its inclusion in an on cycle product, however, is meaningless because it is primarily used by individuals to promote ocular health, which is not a real concern for those on cycle.
And there you have it, a comprehensive review of the best on cycle product on the market (Cycle Assist) versus the latest pretender (Talos). Not only does Cycle Assist include a variety of standardized herbal extracts with clinical trials in humans, but it also includes them at physiologically relevant dosages.
References:
1. Borgström, L.; Kågedal, B.; Paulsen, O. (1986). "Pharmacokinetics of N-acetylcysteine in man". European Journal of Clinical Pharmacology 31 (2): 217–222. doi:10.1007/BF00606662. PMID 3803419.
2. Dilger, R. N.; Baker, D. H. (2007). "Oral N-acetyl-L-cysteine is a safe and effective precursor of cysteine". Journal of Animal Science 85 (7): 1712–8. doi:10.2527/jas.2006-835. PMID 17371789.
3. Kanter, M. Z. (2006). "Comparison of oral and i.v. Acetylcysteine in the treatment of acetaminophen poisoning". American Journal of Health-System Pharmacy 63 (19): 1821–7. doi:10.2146/ajhp060050. PMID 16990628.
4. Dawson, AH; Henry, DA; McEwen, J (1989). "Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning". The Medical journal of Australia 150 (6): 329–31. PMID 2716644.
5. Bailey, B; McGuigan, M (1998). "Management of Anaphylactoid Reactions to Intravenous -Acetylcysteine". Annals of Emergency Medicine 31 (6): 710–5. doi:10.1016/S0196-0644(98)70229-X. PMID 9624310.
6. Schmidt, L. E.; Dalhoff, K (2008). "Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning". British Journal of Clinical Pharmacology 51 (1): 87–91. doi:10.1046/j.1365-2125.2001.01305.x. PMC 2014432. PMID 11167669.
7. Lynch, R; Robertson, R (2004). "Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study". Accident and Emergency Nursing 12 (1): 10–5. doi:10.1016/j.aaen.2003.07.001. PMID 14700565
8. Tepel, Martin; Van Der Giet, Marcus; Schwarzfeld, Carola; Laufer, Ulf; Liermann, Dieter; Zidek, Walter (2000). "Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine". New England Journal of Medicine 343 (3): 180–4. doi:10.1056/NEJM200007203430304. PMID 10900277.
9. Hoffmann, U.; Fischereder, M; Krüger, B; Drobnik, W; Krämer, BK (2004). "The Value of N-Acetylcysteine in the Prevention of Radiocontrast Agent-Induced Nephropathy Seems Questionable". Journal of the American Society of Nephrology 15 (2): 407–10. doi:10.1097/01.ASN.0000106780.14856.55. PMID 14747387.
10. Miner, S; Dzavik, V; Nguyen-Ho, P; Richardson, R; Mitchell, J; Atchison, D; Seidelin, P; Daly, P; Ross, J et al. (2004). "N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up". American Heart Journal 148 (4): 690–5. doi:10.1016/j.ahj.2004.05.015. PMID 15459602.
11. Marenzi, Giancarlo; Assanelli, Emilio; Marana, Ivana; Lauri, Gianfranco; Campodonico, Jeness; Grazi, Marco; De Metrio, Monica; Galli, Stefano; Fabbiocchi, Franco et al. (2006). "N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty". New England Journal of Medicine 354 (26): 2773–82. doi:10.1056/NEJMoa054209. PMID 16807414.
12. Kay, J.; Chow, WH; Chan, TM; Lo, SK; Kwok, OH; Yip, A; Fan, K; Lee, CH; Lam, WF (2003). "Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention: A Randomized Controlled Trial". JAMA 289 (5): 553–8. doi:10.1001/jama.289.5.553. PMID 12578487.
13. Act, Investigators (September 2011). "Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT)". Circulation 124 (11): 1250–9.
14. Szilárd, S; Szentgyörgyi, D; Demeter, I (1988). "Protective effect of Legalon in workers exposed to organic solvents". Acta medica Hungarica 45 (2): 249–56. PMID 3073356.
15. Palasciano, Giuseppe; Portincasa, Piero; Palmieri, Vincenzo; Ciani, Daniela; Vendemiale, Gianluigi; Altomare, Emanuele (1994). "The effect of silymarin on plasma levels of malon-dialdehyde in patients receiving long-term treatment with psychotropic drugs". Current Therapeutic Research 55 (5): 537–45. doi:10.1016/S0011-393X(05)80184-5.
16. Angulo, P; Patel, T; Jorgensen, RA; Therneau, TM; Lindor, KD (2000). "Silymarin in the Treatment of Patients with Primary Biliary Cirrhosis with a Suboptimal Response to Ursodeoxycholic Acid". Hepatology 32 (5): 897–900. doi:10.1053/jhep.2000.18663. PMID 11050036.
17. Lieber, Charles S.; Leo, Maria A.; Cao, Qi; Ren, Chaoling; Decarli, Leonore M. (2003). "Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons". Journal of Clinical Gastroenterology 37 (4): 336–9. doi:10.1097/00004836-200310000-00013. PMID 14506392.
18. Ladas, Elena J.; Kroll, David J.; Oberlies, Nicholas H.; Cheng, Bin; Ndao, Deborah H.; Rheingold, Susan R.; Kelly, Kara M. (2010). "A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL)". Cancer 116 (2): 506–13. doi:10.1002/cncr.24723. PMC 3542639. PMID 20014183.
19. Naruta, E.; Buko, V. (2001). "Hypolipidemic effect of pantothenic acid derivatives in mice with hypothalamic obesity induced by aurothioglucose". Experimental and Toxologic Pathology 53 (5): 393–398. doi:10.1078/0940-2993-00205. PMID 11817109.
20. Harry Fong & Jerry Bauman 2002. Alternative Medicines for Cardiovascular Diseases--Hawthorn, Journal of Cardiovascular Nursing 16(4):1-8.
21. Sweet JMRBV (2002). Hawthorn: Pharmacology and therapeutic uses. American Journal of Health-System Pharmacy 59: 417-422.
22. Miodownik C, Lerner V, Vishne T, et al. High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary study. Clin Neuropharmacol 2007 Jan-Feb;30(1):13-7.
23. Schnyder G, Roffi M, Flammer Y, et al. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 8-28-2002;288(8):973-979.
24. Markowitz JS, Donovan JL, Devane CL, et al. (December 2003). "Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers". Clin. Pharmacol. Ther. 74 (6): 536–42. doi:10.1016/j.clpt.2003.08.010. PMID 14663456.
25. Wilt T, Ishani A, Mac Donald R (2002). "Serenoa repens for benign prostatic hyperplasia". In Tacklind, James. Cochrane Database Syst Rev (3): CD001423. doi:10.1002/14651858.CD001423. PMID 12137626.
26. Bent S, Kane C, Shinohara K, et al. (February 2006). "Saw palmetto for benign prostatic hyperplasia". N. Engl. J. Med. 354 (6): 557–66. doi:10.1056/NEJMoa053085. PMID 16467543.
27. Dedhia RC, McVary KT (June 2008). "Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia". J. Urol. 179 (6): 2119–25.
28. "Saw Palmetto". MedlinePlus (National Library of Medicine). 2008-02-01.
29. Sultana, S., Ahmed, S., Jahangir, T., & Sharma, S. (2005). Inhibitory effect of celery seeds extract on chemically induced hepatocarcinogenesis: modulation of cell proliferation, metabolism and altered hepatic foci development. Cancer letters, 221(1), 11-20.
30. Le QT, Elliott WJ. Hypotensive and hypocholesterolemic effects of celery oil may be due to BuPh. Clin Res. 1991;39:173A.
31. Bagchi, Debasis; Sen, Chandan K; Ray, Sidhartha D; Das, Dipak K; Bagchi, Manashi; Preuss, Harry G; Vinson, Joe A (2003). "Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract". Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 523-524: 87–97. doi:10.1016/S0027-5107(02)00324-X. PMID 12628506
32. Vitseva, Olga; Varghese, Sonia; Chakrabarti, Subrata; Folts, John D; Freedman, Jane E (2005). "Grape Seed and Skin Extracts Inhibit Platelet Function and Release of Reactive Oxygen Intermediates". Journal of Cardiovascular Pharmacology 46 (4): 445–51.
33. Pan, Xinjuan; Dai, Yujie; Li, Xing; Niu, Nannan; Li, Wenjie; Liu, Fangli; Zhao, Yang; Yu, Zengli (2011). "Inhibition of arsenic induced-rat liver injury by grape seed exact through suppression of NADPH oxidase and TGF-β/Smad activation". Toxicology and Applied Pharmacology 254 (3): 323–31. doi:10.1016/j.taap.2011.04.022. PMID 21605584.
34. Liu, S.; Tan, M. Y.; Zhao, S. P.; Rong, H. (2012). "Effects of policosanol on serum lipids and heme oxygenase-1 in patients with hyperlipidemia". Zhonghua xin xue guan bing za zhi 40 (10): 840–843. PMID 23302671. edit
35. Zanardi, M.; Quirico, E.; Benvenuti, C.; Pezzana, A. (2012). "Use of a lipid-lowering food supplement in patients on hormone therapy following breast cancer". Minerva ginecologica 64 (5): 431–435. PMID 23018482.
36. Blando, F., Gerardi, C., & Nicoletti, I. (2004). Sour Cherry (Prunus cerasus L) Anthocyanins as Ingredients for Functional Foods. Journal of Biomedicine and Biotechnology, 2004(5), 253-258. Hindawi Publishing Corporation.
37. Higashiyama, K.; Takeuchi, Y.; Yamauchi, T.; Imai, S.; Kamei, J.; Yajima, Y.; Narita, M.; Suzuki, T. (May 2005). "Implication of the Descending Dynorphinergic Neuron Projecting to the Spinal Cord in the (+)-Matrine- and (+)-Allomatrine-Induced Antinociceptive Effects" (pdf). Biological and Pharmaceutical Bulletin 28 (5): 845–848. doi:10.1248/bpb.28.845. PMID 15863891.
38. Ma, L.; Wen, S.; Zhan, Y.; He, Y.; Liu, X.; Jiang, J. (2008). "Anticancer Effects of the Chinese Medicine Matrine on Murine Hepatocellular Carcinoma Cells". Planta Medica 74 (3): 245–251. doi:10.1055/s-2008-1034304. PMID 18283616.
39. Wenzel, E., & Somoza, V. (2005). Metabolism and bioavailability of trans-resveratrol. Molecular nutrition & food research, 49(5), 472-481.
40. Xue, L. X. (1993). Experimental study on extract of Dunaliella salina in preventing NSAR-induced cancer of proventriculus in mice. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 27(6), 350-353.
41. Herrero, M., Ibáñez, E., Cifuentes, A., Reglero, G., & Santoyo, S. (2006). Dunaliella salina microalga pressurized liquid extracts as potential antimicrobials. Journal of food protection, 69(10), 2471-2477.
so yes it is underdosed ..and the SAMe is actually 200mgs
